Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Scribe Therapeutics Inc. SCTX

Full chart Compare

Set alert

16.86 USD -0.50 (-2.88%)

At closeNov 11, 2026, 4:00 PM EST

16.63 -0.23 -1.36%

After hours · Nov 11, 4:00 PM ET

16.70 Day range 17.76

13.50 52-week range 39.60

YTD: -11.12%
1 year: -11.12%

News

6 days ago globenewswire.com Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences ALAMEDA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics” or “the Company”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built…
1 week ago benzinga.com Scribe Therapeutics To Present Data In American Heart Association’s Scientific Sessions On Its Three Clinical Programs Scribe Therapeutics Inc. ("Scribe Therapeutics" or "the Company") (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend…
4 weeks ago benzinga.com Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire’s $330M investment. Liquidia and Verastem also posted strong gains.